title: Antimitochondrial autoantibodies in myocardial hypertrophy: comparison between hypertrophic cardiomyopathy, hypertensive heart disease, and athlete's heart.
abstract: Antimitochondrial autoantibodies (AMA) were tested by indirect immunofluorescence in three groups of subjects with different types of myocardial hypertrophy: 35 patients affected with hypertrophic cardiomyopathy (HC), 20 patients with cardiac hypertrophy secondary to essential hypertension, and 35 active endurance athletes with exercise-induced left ventricular hypertrophy. Forty-two healthy subjects served as a control group. Left ventricular hypertrophy was considered a left ventricular mass (LVM) echocardiographically calculated (Devereux formula), exceeding 244 gm or a LVM index exceeding 122 gm/m2 (greater than 2 SD from a previously studied normal population). AMA were found in 15 of 35 (43%) patients with HC and in 6 of 20 (30%) patients with hypertensive heart disease (p less than 0.01); in contrast, AMA were not present in the sera of athletes or in the sera of controls. Although the significance of AMA in subjects with pathologic myocardial hypertrophy has not yet been established, their absence in the sera of athletes strengthens the opinion that cellular changes, as a compensatory response of the myocardium to a work overload, have a physiologic fashion in these cases. Moreover, identification of AMA in the sera of athletes with disproportionate severe left ventricular hypertrophy of uncertain origin may be helpful to ensure a single diagnosis.
authors.affiliation: Department of Internal Medicine, II University of Rome, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Autore
authors.forename: S
authors.initials: S
authors.lastname: Fiorito
authors.forename: A
authors.initials: A
authors.lastname: Pelliccia
authors.forename: G
authors.initials: G
authors.lastname: Caselli
authors.forename: P V
authors.initials: PV
authors.lastname: Fragola
authors.forename: A
authors.initials: A
authors.lastname: Picelli
authors.forename: A M
authors.initials: AM
authors.lastname: Maccari
authors.forename: D
authors.initials: D
authors.lastname: Pocobelli
authors.forename: D
authors.initials: D
authors.lastname: Cannata
authors.forename: M
authors.initials: M
authors.lastname: Sangiorgi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis*; D006332:Cardiomegaly / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D002312:Cardiomyopathy, Hypertrophic / Q000276:immunology* / Q000473:pathology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D007136:Immunoglobulins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D008929:Mitochondria, Heart / Q000276:immunology*; D009130:Muscle, Smooth / Q000276:immunology; D009206:Myocardium / Q000473:pathology; D010295:Parietal Cells, Gastric / Q000276:immunology; D013177:Sports
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D007136:Immunoglobulins